Recombinant OSMR (Vixarelimab Biosimilar) antibody (PE)

Catalog No. ABIN7867395

The Human Monoclonal anti-OSMR (Vixarelimab Biosimilar) antibody is suitable to detect OSMR (Vixarelimab Biosimilar) in samples from Human. It has been validated for FACS.

Quick Overview for Recombinant OSMR (Vixarelimab Biosimilar) antibody (PE) (ABIN7867395)

Target: OSMR (Vixarelimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This OSMR (Vixarelimab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Product Details anti-OSMR (Vixarelimab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-OSMR(vixarelimab biosimilar) mAb

Isotype: IgG4, lambda

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for OSMR (Vixarelimab Biosimilar)

Target: OSMR (Vixarelimab Biosimilar)

Alternative Name: vixarelimab biosimilar

Target Type: Biosimilar

Background:

Synonyms: IL-31 receptor subunit beta,IL-31R subunit beta,IL-31R-beta,IL-31RB,KPL-716

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

UniProt: Q99650